2C-x: Difference between revisions
>Tracer Added Category:Chemical class |
>PsychoticCorpse m Added a description of what phenethylamine is to the chemistry section, which formerly stated only where the substitutions occurred assuming the reader already knows what the structure of phenethylamine. |
||
Line 6: | Line 6: | ||
All derivatives of [[2,5-dimethoxyphenethylamine]] have a [[phenethylamine]] backbone with two methoxy groups in positions 2 and 5 of the aromatic ring and they further contain different lipophilic substituents in position 4. | All derivatives of [[2,5-dimethoxyphenethylamine]] have a [[phenethylamine]] backbone with two methoxy groups in positions 2 and 5 of the aromatic ring and they further contain different lipophilic substituents in position 4. | ||
==List of 2C-x compounds == | The phenethylamine backbone consists of a phenyl ring joined to an amine group through an ethyl chain. All compounds in the 2C-x series consist of this as their core structure. | ||
==List of 2C-x compounds== | |||
===Classic 2C-x compounds=== | ===Classic 2C-x compounds=== | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
! scope="col" | '''Compound''' | ! scope="col" |'''Compound''' | ||
! scope="col" style="width: 50px;" | '''R<sub>4</sub>''' | ! scope="col" style="width: 50px;" |'''R<sub>4</sub>''' | ||
! scope="col" | '''Structure''' | ! scope="col" |'''Structure''' | ||
|- | |- | ||
| [[2C-B]] || Br || [[File:2C-B.svg|200px]] | |[[2C-B]]||Br||[[File:2C-B.svg|200px]] | ||
|- | |- | ||
| [[2C-C]] || Cl || [[File:2C-C.svg|200px]] | |[[2C-C]]||Cl||[[File:2C-C.svg|200px]] | ||
|- | |- | ||
| [[2C-D]] || CH<sub>3</sub> || [[File:2C-D.svg|200px]] | |[[2C-D]]||CH<sub>3</sub>||[[File:2C-D.svg|200px]] | ||
|- | |- | ||
| [[2C-E]] || CH<sub>2</sub>CH<sub>3</sub> || [[File:2C-E.svg|200px]] | |[[2C-E]]||CH<sub>2</sub>CH<sub>3</sub>||[[File:2C-E.svg|200px]] | ||
|- | |- | ||
| [[2C-H]] || H || [[File:2C-H.svg|200px]] | |[[2C-H]]||H||[[File:2C-H.svg|200px]] | ||
|- | |- | ||
| [[2C-I]] || I || [[File:2C-I.svg|200px]] | |[[2C-I]]||I||[[File:2C-I.svg|200px]] | ||
|- | |- | ||
| 2C-iP || CH<sub></sub>(CH<sub>3</sub>)<sub>2</sub> || [[File:2C-iP.svg|200px]] | |2C-iP||CH<sub></sub>(CH<sub>3</sub>)<sub>2</sub>||[[File:2C-iP.svg|200px]] | ||
|- | |- | ||
| [[2C-P]] || CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> || [[File:2C-P.svg|200px]] | |[[2C-P]]||CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>||[[File:2C-P.svg|200px]] | ||
|- | |- | ||
| 2C-TFM || CF<sub>3</sub> || [[File:2C-TFM.svg|201px]] | |2C-TFM||CF<sub>3</sub>||[[File:2C-TFM.svg|201px]] | ||
|- | |- | ||
| 2C-T<!-- general structure for a 2C-T-x compound --> || SCH<sub>3</sub> || [[File:2C-T.svg|200px]] | |2C-T<!-- general structure for a 2C-T-x compound -->||SCH<sub>3</sub>||[[File:2C-T.svg|200px]] | ||
|- | |- | ||
| [[2C-T-2]] || SCH<sub>2</sub>CH<sub>3</sub> || [[File:2C-T-2.svg|200px]] | |[[2C-T-2]]||SCH<sub>2</sub>CH<sub>3</sub>||[[File:2C-T-2.svg|200px]] | ||
|- | |- | ||
| 2C-T-4 || SCH(CH<sub>3</sub>)<sub>2</sub> || [[File:2C-T-4.svg|200px]] | |2C-T-4||SCH(CH<sub>3</sub>)<sub>2</sub>||[[File:2C-T-4.svg|200px]] | ||
|- | |- | ||
| [[2C-T-7]] || SCH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> || [[File:2C-T-7.svg|200px]] | |[[2C-T-7]]||SCH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>||[[File:2C-T-7.svg|200px]] | ||
|- | |- | ||
| [[2C-T-21]] || SCH<sub>2</sub>CH<sub>2</sub>F || [[File:2C-T-21.svg|200px]] | |[[2C-T-21]]||SCH<sub>2</sub>CH<sub>2</sub>F||[[File:2C-T-21.svg|200px]] | ||
|- | |- | ||
|} | |} | ||
Line 46: | Line 48: | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
! scope="col" | '''Compound''' | ! scope="col" |'''Compound''' | ||
! scope="col" style="width: 50px;" | '''R<sub>3</sub>''' | ! scope="col" style="width: 50px;" |'''R<sub>3</sub>''' | ||
! scope="col" style="width: 50px;" | '''R<sub>4</sub>''' | ! scope="col" style="width: 50px;" |'''R<sub>4</sub>''' | ||
! scope="col" style="width: 50px;" | '''R<sub>6</sub>''' | ! scope="col" style="width: 50px;" |'''R<sub>6</sub>''' | ||
! scope="col" style="width: 50px;" | '''R<sub>β</sub>''' | ! scope="col" style="width: 50px;" |'''R<sub>β</sub>''' | ||
! scope="col" | '''Structure''' | ! scope="col" |'''Structure''' | ||
|- | |- | ||
| [[βk-2C-B]] || H || Br || H || =O || [[File:Βk-2C-B.svg|200px]] | |[[βk-2C-B]]||H||Br||H||=O||[[File:Βk-2C-B.svg|200px]] | ||
|- | |- | ||
| [[2C-B-FLY]] || CH<sub>2</sub>- || Br || CH<sub>2</sub>- || H || [[File:2C-B-FLY.svg|200px]] | |[[2C-B-FLY]]||CH<sub>2</sub>-||Br||CH<sub>2</sub>-||H||[[File:2C-B-FLY.svg|200px]] | ||
|- | |- | ||
|} | |} | ||
Line 68: | Line 70: | ||
==Legal status== | ==Legal status== | ||
*'''Austria:''' The 2C-x family is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich) or the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).{{citation needed}} | *'''Austria:''' The 2C-x family is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich) or the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).{{citation needed}} | ||
*'''USA:''' In the US, most of the 2C-x chemicals are Schedule I under the American Food and Drug Administration Safety and Innovation Act of 2012 and the Federal Analogue Act.<ref>http://www.justice.gov/ola/views-letters/112/093011-ltr-re-hr1254-synthetic-drug-control-act-2011.pdf</ref> | *'''USA:''' In the US, most of the 2C-x chemicals are Schedule I under the American Food and Drug Administration Safety and Innovation Act of 2012 and the Federal Analogue Act.<ref>http://www.justice.gov/ola/views-letters/112/093011-ltr-re-hr1254-synthetic-drug-control-act-2011.pdf</ref> | ||
Line 77: | Line 80: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[DOx]] | *[[DOx]] | ||
Line 85: | Line 89: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/2C_(psychedelics) 2C (Wikipedia)] | *[https://en.wikipedia.org/wiki/2C_(psychedelics) 2C (Wikipedia)] | ||
==Literature== | ==Literature== | ||
* Dean, B. V., Stellpflug, S. J., Burnett, A. M., & Engebretsen, K. M. (2013). 2C or not 2C: Phenethylamine Designer Drug Review. Journal of Medical Toxicology, 9(2), 172-178. https://doi.org/10.1007/s13181-013-0295-x | |||
*Dean, B. V., Stellpflug, S. J., Burnett, A. M., & Engebretsen, K. M. (2013). 2C or not 2C: Phenethylamine Designer Drug Review. Journal of Medical Toxicology, 9(2), 172-178. https://doi.org/10.1007/s13181-013-0295-x | |||
==References== | ==References== |